The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Exosome Marker Antibodies Market Research Report 2024
Synopsis
Exosomes are small vesicles composed of a lipid bilayer. Exosomes are formed when certain endosomes, called multivesicular bodies, fuse with the plasma membrane, releasing them into the extracellular environment. They may also be directly released from the plasma membrane. Exosomal marker antibodies are designed to dependably detect the key exosomal targets.
Global Exosome Marker Antibodies market is projected to reach US$ 945.5 million in 2029, increasing from US$ 463 million in 2022, with the CAGR of 10.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Exosome Marker Antibodies market research.
Key manufacturers engaged in the Exosome Marker Antibodies industry include Novus Biologicals, Thermo Fisher Scientific, System Biosciences, Creative Bioarray, MBL International, FUJIFILM Wako, Qiagen, Miltenyi Biotech and Beckman Coulter, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Exosome Marker Antibodies were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Exosome Marker Antibodies market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Exosome Marker Antibodies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novus Biologicals
Thermo Fisher Scientific
System Biosciences
Creative Bioarray
MBL International
FUJIFILM Wako
Qiagen
Miltenyi Biotech
Beckman Coulter
ABP Biosciences
BioVision
Alpha Laboratories
BioCat GmbH
RayBiotech
Segment by Type
Tetraspanins
Multivesicular Body (MVB)-Associated Proteins
Others
Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Company
Hospitals and Clinical
Testing Laboratories
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Exosome Marker Antibodies report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Exosomes are small vesicles composed of a lipid bilayer. Exosomes are formed when certain endosomes, called multivesicular bodies, fuse with the plasma membrane, releasing them into the extracellular environment. They may also be directly released from the plasma membrane. Exosomal marker antibodies are designed to dependably detect the key exosomal targets.
Global Exosome Marker Antibodies market is projected to reach US$ 945.5 million in 2029, increasing from US$ 463 million in 2022, with the CAGR of 10.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Exosome Marker Antibodies market research.
Key manufacturers engaged in the Exosome Marker Antibodies industry include Novus Biologicals, Thermo Fisher Scientific, System Biosciences, Creative Bioarray, MBL International, FUJIFILM Wako, Qiagen, Miltenyi Biotech and Beckman Coulter, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Exosome Marker Antibodies were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Exosome Marker Antibodies market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Exosome Marker Antibodies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novus Biologicals
Thermo Fisher Scientific
System Biosciences
Creative Bioarray
MBL International
FUJIFILM Wako
Qiagen
Miltenyi Biotech
Beckman Coulter
ABP Biosciences
BioVision
Alpha Laboratories
BioCat GmbH
RayBiotech
Segment by Type
Tetraspanins
Multivesicular Body (MVB)-Associated Proteins
Others
Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Company
Hospitals and Clinical
Testing Laboratories
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Exosome Marker Antibodies report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Exosome Marker Antibodies Market Overview
1.1 Product Overview and Scope of Exosome Marker Antibodies
1.2 Exosome Marker Antibodies Segment by Type
1.2.1 Global Exosome Marker Antibodies Market Value Comparison by Type (2023-2029)
1.2.2 Tetraspanins
1.2.3 Multivesicular Body (MVB)-Associated Proteins
1.2.4 Others
1.3 Exosome Marker Antibodies Segment by Application
1.3.1 Global Exosome Marker Antibodies Market Value by Application: (2023-2029)
1.3.2 Academic and Research Institutes
1.3.3 Pharmaceutical and Biotechnology Company
1.3.4 Hospitals and Clinical
1.3.5 Testing Laboratories
1.3.6 Others
1.4 Global Exosome Marker Antibodies Market Size Estimates and Forecasts
1.4.1 Global Exosome Marker Antibodies Revenue 2018-2029
1.4.2 Global Exosome Marker Antibodies Sales 2018-2029
1.4.3 Global Exosome Marker Antibodies Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Exosome Marker Antibodies Market Competition by Manufacturers
2.1 Global Exosome Marker Antibodies Sales Market Share by Manufacturers (2018-2023)
2.2 Global Exosome Marker Antibodies Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Exosome Marker Antibodies Average Price by Manufacturers (2018-2023)
2.4 Global Exosome Marker Antibodies Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Exosome Marker Antibodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Exosome Marker Antibodies, Product Type & Application
2.7 Exosome Marker Antibodies Market Competitive Situation and Trends
2.7.1 Exosome Marker Antibodies Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Exosome Marker Antibodies Players Market Share by Revenue
2.7.3 Global Exosome Marker Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Exosome Marker Antibodies Retrospective Market Scenario by Region
3.1 Global Exosome Marker Antibodies Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Exosome Marker Antibodies Global Exosome Marker Antibodies Sales by Region: 2018-2029
3.2.1 Global Exosome Marker Antibodies Sales by Region: 2018-2023
3.2.2 Global Exosome Marker Antibodies Sales by Region: 2024-2029
3.3 Global Exosome Marker Antibodies Global Exosome Marker Antibodies Revenue by Region: 2018-2029
3.3.1 Global Exosome Marker Antibodies Revenue by Region: 2018-2023
3.3.2 Global Exosome Marker Antibodies Revenue by Region: 2024-2029
3.4 North America Exosome Marker Antibodies Market Facts & Figures by Country
3.4.1 North America Exosome Marker Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Exosome Marker Antibodies Sales by Country (2018-2029)
3.4.3 North America Exosome Marker Antibodies Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Exosome Marker Antibodies Market Facts & Figures by Country
3.5.1 Europe Exosome Marker Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Exosome Marker Antibodies Sales by Country (2018-2029)
3.5.3 Europe Exosome Marker Antibodies Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Exosome Marker Antibodies Market Facts & Figures by Country
3.6.1 Asia Pacific Exosome Marker Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Exosome Marker Antibodies Sales by Country (2018-2029)
3.6.3 Asia Pacific Exosome Marker Antibodies Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Exosome Marker Antibodies Market Facts & Figures by Country
3.7.1 Latin America Exosome Marker Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Exosome Marker Antibodies Sales by Country (2018-2029)
3.7.3 Latin America Exosome Marker Antibodies Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Exosome Marker Antibodies Market Facts & Figures by Country
3.8.1 Middle East and Africa Exosome Marker Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Exosome Marker Antibodies Sales by Country (2018-2029)
3.8.3 Middle East and Africa Exosome Marker Antibodies Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Exosome Marker Antibodies Sales by Type (2018-2029)
4.1.1 Global Exosome Marker Antibodies Sales by Type (2018-2023)
4.1.2 Global Exosome Marker Antibodies Sales by Type (2024-2029)
4.1.3 Global Exosome Marker Antibodies Sales Market Share by Type (2018-2029)
4.2 Global Exosome Marker Antibodies Revenue by Type (2018-2029)
4.2.1 Global Exosome Marker Antibodies Revenue by Type (2018-2023)
4.2.2 Global Exosome Marker Antibodies Revenue by Type (2024-2029)
4.2.3 Global Exosome Marker Antibodies Revenue Market Share by Type (2018-2029)
4.3 Global Exosome Marker Antibodies Price by Type (2018-2029)
5 Segment by Application
5.1 Global Exosome Marker Antibodies Sales by Application (2018-2029)
5.1.1 Global Exosome Marker Antibodies Sales by Application (2018-2023)
5.1.2 Global Exosome Marker Antibodies Sales by Application (2024-2029)
5.1.3 Global Exosome Marker Antibodies Sales Market Share by Application (2018-2029)
5.2 Global Exosome Marker Antibodies Revenue by Application (2018-2029)
5.2.1 Global Exosome Marker Antibodies Revenue by Application (2018-2023)
5.2.2 Global Exosome Marker Antibodies Revenue by Application (2024-2029)
5.2.3 Global Exosome Marker Antibodies Revenue Market Share by Application (2018-2029)
5.3 Global Exosome Marker Antibodies Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novus Biologicals
6.1.1 Novus Biologicals Corporation Information
6.1.2 Novus Biologicals Description and Business Overview
6.1.3 Novus Biologicals Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novus Biologicals Exosome Marker Antibodies Product Portfolio
6.1.5 Novus Biologicals Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Corporation Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Thermo Fisher Scientific Exosome Marker Antibodies Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 System Biosciences
6.3.1 System Biosciences Corporation Information
6.3.2 System Biosciences Description and Business Overview
6.3.3 System Biosciences Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.3.4 System Biosciences Exosome Marker Antibodies Product Portfolio
6.3.5 System Biosciences Recent Developments/Updates
6.4 Creative Bioarray
6.4.1 Creative Bioarray Corporation Information
6.4.2 Creative Bioarray Description and Business Overview
6.4.3 Creative Bioarray Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Creative Bioarray Exosome Marker Antibodies Product Portfolio
6.4.5 Creative Bioarray Recent Developments/Updates
6.5 MBL International
6.5.1 MBL International Corporation Information
6.5.2 MBL International Description and Business Overview
6.5.3 MBL International Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.5.4 MBL International Exosome Marker Antibodies Product Portfolio
6.5.5 MBL International Recent Developments/Updates
6.6 FUJIFILM Wako
6.6.1 FUJIFILM Wako Corporation Information
6.6.2 FUJIFILM Wako Description and Business Overview
6.6.3 FUJIFILM Wako Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.6.4 FUJIFILM Wako Exosome Marker Antibodies Product Portfolio
6.6.5 FUJIFILM Wako Recent Developments/Updates
6.7 Qiagen
6.6.1 Qiagen Corporation Information
6.6.2 Qiagen Description and Business Overview
6.6.3 Qiagen Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Qiagen Exosome Marker Antibodies Product Portfolio
6.7.5 Qiagen Recent Developments/Updates
6.8 Miltenyi Biotech
6.8.1 Miltenyi Biotech Corporation Information
6.8.2 Miltenyi Biotech Description and Business Overview
6.8.3 Miltenyi Biotech Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Miltenyi Biotech Exosome Marker Antibodies Product Portfolio
6.8.5 Miltenyi Biotech Recent Developments/Updates
6.9 Beckman Coulter
6.9.1 Beckman Coulter Corporation Information
6.9.2 Beckman Coulter Description and Business Overview
6.9.3 Beckman Coulter Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Beckman Coulter Exosome Marker Antibodies Product Portfolio
6.9.5 Beckman Coulter Recent Developments/Updates
6.10 ABP Biosciences
6.10.1 ABP Biosciences Corporation Information
6.10.2 ABP Biosciences Description and Business Overview
6.10.3 ABP Biosciences Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.10.4 ABP Biosciences Exosome Marker Antibodies Product Portfolio
6.10.5 ABP Biosciences Recent Developments/Updates
6.11 BioVision
6.11.1 BioVision Corporation Information
6.11.2 BioVision Exosome Marker Antibodies Description and Business Overview
6.11.3 BioVision Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.11.4 BioVision Exosome Marker Antibodies Product Portfolio
6.11.5 BioVision Recent Developments/Updates
6.12 Alpha Laboratories
6.12.1 Alpha Laboratories Corporation Information
6.12.2 Alpha Laboratories Exosome Marker Antibodies Description and Business Overview
6.12.3 Alpha Laboratories Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Alpha Laboratories Exosome Marker Antibodies Product Portfolio
6.12.5 Alpha Laboratories Recent Developments/Updates
6.13 BioCat GmbH
6.13.1 BioCat GmbH Corporation Information
6.13.2 BioCat GmbH Exosome Marker Antibodies Description and Business Overview
6.13.3 BioCat GmbH Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.13.4 BioCat GmbH Exosome Marker Antibodies Product Portfolio
6.13.5 BioCat GmbH Recent Developments/Updates
6.14 RayBiotech
6.14.1 RayBiotech Corporation Information
6.14.2 RayBiotech Exosome Marker Antibodies Description and Business Overview
6.14.3 RayBiotech Exosome Marker Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.14.4 RayBiotech Exosome Marker Antibodies Product Portfolio
6.14.5 RayBiotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Exosome Marker Antibodies Industry Chain Analysis
7.2 Exosome Marker Antibodies Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Exosome Marker Antibodies Production Mode & Process
7.4 Exosome Marker Antibodies Sales and Marketing
7.4.1 Exosome Marker Antibodies Sales Channels
7.4.2 Exosome Marker Antibodies Distributors
7.5 Exosome Marker Antibodies Customers
8 Exosome Marker Antibodies Market Dynamics
8.1 Exosome Marker Antibodies Industry Trends
8.2 Exosome Marker Antibodies Market Drivers
8.3 Exosome Marker Antibodies Market Challenges
8.4 Exosome Marker Antibodies Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
